Parallax Volatility Advisers, L.P. Relmada Therapeutics, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	BUY	$16.72 - $26.99 $891,175 - $1.44 Million	53,300 New	53,300 $1.44 Million
Q1 2021 May 14, 2021	SELL	$31.52 - $39.28 $1.14 Million - $1.42 Million	-36,200 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$31.52 - $39.28 $1.14 Million - $1.42 Million	36,200 New	36,200 $1.28 Million
Q3 2020 Nov 13, 2020	SELL	$34.42 - $43.78 $1.52 Million - $1.94 Million	-44,300 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$31.59 - $49.98 $1.4 Million - $2.21 Million	44,300 New	44,300 $1.98 Million

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $11.7M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.